Yiming Li Selected Research

Sepsis (Septicemia)

4/2022	[Transcriptome changes upon Toll-like receptor 9 pathway activation in primary renal tubular epithelial cells].
2/2022	Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI.
1/2021	Acetate Ringer's solution versus 0.9% saline for septic patients: study protocol for a multi-center parallel controlled trial.
1/2020	Csf2 Attenuated Sepsis-Induced Acute Kidney Injury by Promoting Alternative Macrophage Transition.
1/2020	Analysis of Spatiotemporal Urine Protein Dynamics to Identify New Biomarkers for Sepsis-Induced Acute Kidney Injury.
1/2019	TLR9 signaling in fibroblastic reticular cells regulates peritoneal immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiming Li Research Topics

Disease

78	Neoplasms (Cancer) 06/2022 - 03/2002
22	Inflammation (Inflammations) 02/2022 - 06/2012
20	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2010
17	Glioma (Gliomas) 09/2022 - 09/2012
15	Body Weight (Weight, Body) 07/2021 - 11/2010
12	Acromegaly 09/2021 - 09/2016
12	Obesity 09/2021 - 12/2010
11	Insulin Resistance 01/2022 - 11/2010
10	COVID-19 01/2022 - 01/2020
10	Pituitary Neoplasms (Pituitary Adenoma) 09/2021 - 10/2012
9	Infections 01/2022 - 01/2013
9	Peripheral Nervous System Diseases (PNS Diseases) 09/2021 - 01/2013
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2014
8	Diabetes Mellitus 01/2022 - 02/2011
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2012
7	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2007
7	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 08/2009
6	Sepsis (Septicemia) 04/2022 - 01/2019
6	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2011
6	Pituitary ACTH Hypersecretion 01/2022 - 03/2015
6	Weight Gain 01/2021 - 12/2010
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 08/2006
5	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 01/2014
5	Hemorrhage 02/2022 - 01/2011
5	Growth Hormone-Secreting Pituitary Adenoma 01/2022 - 11/2018
5	Carcinogenesis 01/2022 - 03/2002
5	Critical Illness (Critically Ill) 01/2021 - 01/2018
5	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2007
5	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 03/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2020 - 06/2009
5	Dentin Sensitivity 01/2019 - 11/2002
5	Hyperglycemia 07/2014 - 06/2009
4	Squamous Cell Carcinoma of Head and Neck 04/2022 - 01/2020
4	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 01/2016
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 08/2013
4	Hypoxia (Hypoxemia) 12/2020 - 04/2017
4	Adenoma (Adenomas) 04/2020 - 03/2015
4	Cushing Syndrome 01/2020 - 03/2015
4	Portal Hypertension 07/2019 - 06/2013
4	Fibrosis (Cirrhosis) 01/2018 - 07/2011
4	Diabetic Cardiomyopathies 01/2018 - 01/2012
4	Periodontitis 01/2016 - 01/2011
3	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 12/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2021
3	Pain (Aches) 04/2021 - 12/2017

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2007
19	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2012
17	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2014
14	Blood Glucose (Blood Sugar)IBA 06/2021 - 11/2010
13	LipidsIBA 01/2022 - 11/2010
12	Pharmaceutical PreparationsIBA 04/2022 - 06/2009
12	CytokinesIBA 01/2022 - 01/2014
10	Biological ProductsIBA 05/2022 - 02/2011
10	Insulin (Novolin)FDA Link 01/2022 - 11/2010
10	Growth Hormone (Somatotropin)IBA 01/2022 - 01/2017
9	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2009
9	CholesterolIBA 03/2021 - 08/2006
8	NAD (NADH)IBA 09/2021 - 01/2015
7	Messenger RNA (mRNA)IBA 05/2022 - 12/2007
7	Liposomes (Liposome)IBA 01/2022 - 09/2012
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2016
7	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 01/2017
7	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 03/2015
7	Therapeutic UsesIBA 01/2021 - 01/2014
7	AntibodiesIBA 12/2020 - 04/2003
6	oxidized low density lipoproteinIBA 02/2022 - 01/2012
6	Hormones (Hormone)IBA 01/2022 - 07/2014
6	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2020 - 09/2016
5	AntioxidantsIBA 08/2022 - 01/2019
5	Polysaccharides (Glycans)IBA 08/2022 - 01/2012
5	LigandsIBA 05/2022 - 11/2017
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022 - 11/2011
5	VaccinesIBA 01/2022 - 10/2013
5	Indicators and Reagents (Reagents)IBA 09/2021 - 01/2014
5	Streptozocin (Streptozotocin)FDA Link 06/2021 - 01/2016
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 01/2014
5	LDL CholesterolIBA 05/2018 - 01/2012
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2022 - 01/2018
4	Oxygen (Dioxygen)IBA 04/2022 - 05/2018
4	Complement System Proteins (Complement)IBA 01/2022 - 01/2019
4	GlucocorticoidsIBA 01/2021 - 05/2015
4	InterferonsIBA 01/2020 - 01/2014
3	Retinaldehyde (Retinal)IBA 06/2022 - 12/2016
3	Cisplatin (Platino)FDA LinkGeneric 04/2022 - 01/2018
3	InflammasomesIBA 04/2022 - 01/2021
3	LipopolysaccharidesIBA 02/2022 - 01/2021
3	Circular RNAIBA 01/2022 - 03/2020
3	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022 - 10/2012
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2021 - 01/2016
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2012
3	FluoridesIBA 01/2021 - 01/2011
3	Insulin-Like PeptidesIBA 01/2021 - 06/2019
3	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 10/2017

Therapy/Procedure

41	Therapeutics 09/2022 - 03/2002
12	Drug Therapy (Chemotherapy) 04/2022 - 08/2009
9	Immunotherapy 01/2022 - 01/2014
7	Ligation 01/2021 - 01/2014
5	Aftercare (After-Treatment) 01/2020 - 01/2011
4	Lasers (Laser) 09/2022 - 01/2011